The Prognostic Value of Pfetin: A Validation Study in Gastrointestinal Stromal Tumors Using a Commercially Available Antibody - Concepedia

Concepedia

Publication | Open Access

The Prognostic Value of Pfetin: A Validation Study in Gastrointestinal Stromal Tumors Using a Commercially Available Antibody

DOI Full Paper Access

13

Citations

13

References

2013

Year

D. Kubota, Kenta Mukaihara, Akihiko Yoshida, Yoshiyuki Suehara, Tomoyo Saito, Taketo Okubo, Hajime Orita, H. Tsuda, K. Kaneko, Akira Kawai,

Japanese Journal of Clinical Oncology

Abstract

Our observations suggest that the pfetin expression level assessed by the commercial antibody could be a prognostic biomarker in gastrointestinal stromal tumors.

References

	Year	Citations
Regression Models and Life-Tables D. R. Cox Journal of the Royal Statistical Society Series B (Statistical Methodology) Regression ModelsReliability EngineeringConditional LikelihoodEngineeringLife Prediction	1972	38.8K
Nonparametric Estimation from Incomplete Observations Edward L. Kaplan, Paul Meier Journal of the American Statistical Association EngineeringAgingLife PredictionRare Event EstimationMortality Rates	1958	38.7K
Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor Heikki Joensuu, Peter Roberts‎, Maarit Sarlomo‐Rikala, New England Journal of Medicine OncologyGastrointestinal OncologyMalignant DiseaseMedicineGrowth Factor Receptor	2001	2.1K
Pathology and Genetics of Tumours of the Digestive System Histopathology Tumoral PathologyCancer PathologyGastrointestinal OncologyHistopathologyGastroenterology	2001	1.3K
Clinical Cancer Research Horder, William Harnett BMJ MedicineCancer ManagementPathologyClinical Cancer ResearchCancer Registration	1941	1.3K
One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, JAMA	2012	955
Approval Summary: Imatinib Mesylate in the Treatment of Metastatic and/or Unresectable Malignant Gastrointestinal Stromal Tumors Martin H. Cohen, Ann T. Farrell, Robert Justice, The Oncologist Surgical OncologyImatinib MesylateGastrointestinal OncologyMedicineMalignant Disease	2009	428
Gastrointestinal stromal tumor: Consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade Tadashi Hasegawa, Yoshihiro Matsuno, Tadakazu Shimoda, Human Pathology Gastrointestinal OncologyMedicineConsistent Cd117 ImmunostainingHistopathologyGastroenterology	2002	248
Pfetin as a Prognostic Biomarker of Gastrointestinal Stromal Tumors Revealed by Proteomics Yoshiyuki Suehara, Tadashi Kondo, Kunihiko Seki, Clinical Cancer Research	2008	94
Distribution of the auxiliary GABA<sub>B</sub>receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain Michaela Metz, Martin Gassmann, Bernd Fakler, The Journal of Comparative Neurology	2011	83

Page 1